Vanguard Global Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Sell
38,271
-2,685
-7% -$278K ﹤0.01% 897
2026
Q1
$3.96M Buy
+40,956
New +$4.2M ﹤0.01% 846

Other funds holding EHC

Vanguard Global Advisers's EHC Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Encompass Health (EHC) stake by 6.6% in Q2 2026, selling an estimated $278K and leaving 38,271 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #897.

Vanguard Global Advisers first reported a position in EHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.96M in Q1 2026. 586 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Vanguard Global Advisers held 38,271 shares of Encompass Health worth $3.87M as of Q2 2026.
  • Vanguard Global Advisers sold 2,685 Encompass Health shares in Q2 2026, an estimated $278K.
  • Encompass Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #897 holding.
  • Vanguard Global Advisers first reported a position in Encompass Health in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Encompass Health position peaked at $3.96M in Q1 2026.
  • 586 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.